Breaking News Instant updates and real-time market news.

2022-05-05 06:52:51 NS NuStar Energy $15.16 / +0.27 (+1.81%) 06:52 05/05/22 05/05 06:52 05/05/22 06:52	NuStar Energy sees FY22 adjusted EBITDA $700M-$750M "We have continued to make substantial progress on improving our debt metrics, with a debt-to-EBITDA ratio of 3.92 times at the end of the first quarter of 2022, compared to 4.39 times at the end of the first quarter of 2021 and 3.99 times at the end of the fourth quarter of 2021," said CEO Barron. "We had $889 million available on our $1.0 billion unsecured revolving credit facility at the end of the first quarter of 2022. We expect to generate full-year 2022 net income in the range of $200 to $230 million, and continue to expect to generate full-year 2022 adjusted EBITDA in the range of $700-750 million, which at the midpoint, represents seven percent growth over 2021, when adjusted for the sale of the Eastern U.S. and Point Tupper terminals."	05 May

2022-05-05 06:52:51

NuStar Energy

$15.16 / +0.27 (+1.81%)

06:52

05/05/22

05/05

06:52

05/05/22

06:52

NuStar Energy sees FY22 adjusted EBITDA $700M-$750M

"We have continued to make substantial progress on improving our debt metrics, with a debt-to-EBITDA ratio of 3.92 times at the end of the first quarter of 2022, compared to 4.39 times at the end of the first quarter of 2021 and 3.99 times at the end of the fourth quarter of 2021," said CEO Barron. "We had $889 million available on our $1.0 billion unsecured revolving credit facility at the end of the first quarter of 2022. We expect to generate full-year 2022 net income in the range of $200 to $230 million, and continue to expect to generate full-year 2022 adjusted EBITDA in the range of $700-750 million, which at the midpoint, represents seven percent growth over 2021, when adjusted for the sale of the Eastern U.S. and Point Tupper terminals."

05
May

OTHER BREAKING NEWS FROM THE FLY

Earnings	Acer Therapeutics reports Q4 EPS (54c), consensus (37c) » 16:22 03/27/23 03/27 16:22 03/27/23 16:22 ACER Acer Therapeutics / + Cash and cash equivalents… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly ACER Acer Therapeutics / + 03/22/23 Acer Therapeutics: Data presented at SIMD on Urea Cycle Disorders 03/17/23 Acer reports Phase 2 trial of ACER-801 did not achieve statistical significance 03/15/23 Acer Therapeutics announces presentation at upcoming meeting for SIMD 02/13/23 Acer Therapeutics announces full enrollment in Phase 2a trial of ACER-801 ACER Acer Therapeutics / + 11/14/22 Acer Therapeutics reports Q3 EPS (31c), consensus (68c) ACER Acer Therapeutics / + 03/22/23 Biotech Alert: Searches spiking for these stocks today 03/20/23 Biotech Alert: Searches spiking for these stocks today 12/27/22 Fly Intel: Pre-market Movers 12/05/22 Fly Insider: Vapotherm, Applovin among week's notable insider trades
Earnings	Terns Pharmaceuticals reports Q4 EPS (29c), consensus (43c) » 16:20 03/27/23 03/27 16:20 03/27/23 16:20 TERN Terns Pharmaceuticals $9.43 / +0.48 (+5.36%) As of December 31, 2022,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TERN Terns Pharmaceuticals $9.43 / +0.48 (+5.36%) 08:13 Today Terns Pharmaceuticals appoints Kuriakose as CMO of Terns oncology 01/03/23 Suvretta Capital reports 7.0% passive stake in Terns Pharmaceuticals 12/23/22 Terns Pharmaceuticals director Lu acquires 758,620 common shares 12/20/22 Terns Pharmaceuticals reports inducement grants to new employees TERN Terns Pharmaceuticals $9.43 / +0.48 (+5.36%) 02/14/23 JMP Securities Terns Pharmaceuticals initiated with an Outperform at JMP Securities 02/07/23 UBS Terns Pharmaceuticals initiated with a Buy at UBS 01/16/23 Piper Sandler Aligos Therapeutics price target raised to $7 from $3 at Piper Sandler 12/29/22 H.C. Wainwright Terns Pharmaceuticals price target raised to $7 from $6 at H.C. Wainwright TERN Terns Pharmaceuticals $9.43 / +0.48 (+5.36%) 11/09/22 Terns Pharmaceuticals reports Q3 EPS (44c), consensus (52c) 21 Dec TERN Terns Pharmaceuticals $9.43 / +0.48 (+5.36%) 01/03/23 Fly Insider: Terns Pharma, Best Buy among week's notable insider trades 12/27/22 Fly Insider: Terns, Air Transport among week's notable insider trades 12/19/22 Fly Intel: After-Hours Movers
Options	Closing CBOE SPX and VIX Index summary for March 27th » 16:20 03/27/23 03/27 16:20 03/27/23 16:20 VIX Volatility Index S&P 500 Options / + The CBOE Volatility Index… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Options VIX Volatility Index S&P 500 Options / + 03/24/23 Closing CBOE SPX and VIX Index summary for March 24th 03/23/23 Closing CBOE SPX and VIX Index summary for March 23rd 03/22/23 Closing CBOE SPX and VIX Index summary for March 22nd 03/21/23 Closing CBOE SPX and VIX Index summary for March 21st
Earnings	Midwest Holding reports Q4 EPS ($2.57) vs. (82c) last year » 16:18 03/27/23 03/27 16:18 03/27/23 16:18 MDWT Midwest Holding $17.71 / +0.96 (+5.73%) Reports Q4 revenue $8.59M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events MDWT Midwest Holding $17.71 / +0.96 (+5.73%) 12/20/22 Piper Sandler Midwest Holding price target lowered to $14 from $16 at Piper Sandler 10/07/22 Piper Sandler Midwest Holding price target lowered to $15 from $16 at Piper Sandler 05/27/22 Piper Sandler Midwest Holding price target raised to $12 from $10 at Piper Sandler 04/01/22 Piper Sandler Piper downgrades Midwest Holding to Neutral, sees limited premium growth in 2022 03/28/23 Midwest Holding - MDWT
Earnings	PVH Corp. sees FY23 EPS roughly $8.97, consensus $8.92 » 16:17 03/27/23 03/27 16:17 03/27/23 16:17 PVH PVH Corp. $73.62 / +0.71 (+0.97%) Sees FY23 revenue growth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/08/23 PVH Corp. names Amber McCann Chief Communications Office 12/01/22 PVH Corp. rises 10.2% 12/01/22 PVH Corp. rises 10.5% 11/30/22 PVH Corp. jumps 9% to $73.38 after Q3 earnings beat, guidance raise PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS 03/20/23 Goldman Sachs PVH Corp. price target raised to $74 from $67 at Goldman Sachs 02/15/23 Wells Fargo PVH Corp. price target raised to $110 from $85 at Wells Fargo 01/23/23 JPMorgan PVH Corp. price target raised to $95 from $77 at JPMorgan PVH PVH Corp. $73.62 / +0.71 (+0.97%) 16:16 Today PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88 16:15 Today PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 11/30/22 PVH Corp. sees Q4 adjusted EPS $1.65, consensus $1.70 PVH PVH Corp. $73.62 / +0.71 (+0.97%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 12/01/22 Fly Intel: Pre-market Movers 11/30/22 Fly Intel: After-Hours Movers 03/28/23 PVH Corp. - PVH PVH PVH Corp. $73.62 / +0.71 (+0.97%) 13:04 Today PVH Corp. options imply 5.1% move in share price post-earnings
Technical Analysis	NASDAQ market internals summary » 16:17 03/27/23 03/27 16:17 03/27/23 16:17 $NSD NASDAQ Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary
Earnings	Lifeway Foods reports Q4 EPS 5c vs. (1c) last year » 16:16 03/27/23 03/27 16:16 03/27/23 16:16 LWAY Lifeway Foods $6.28 / +0.005 (+0.08%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Applied Molecular Transport engages advisor to explore strategic alternatives » 16:16 03/27/23 03/27 16:16 03/27/23 16:16 AMTI Applied Molecular Transport / + Applied Molecular… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AMTI Applied Molecular Transport / + 16:04 Today Applied Molecular Transport CEO Tahir Mahmood to leave in workforce reduction 16:00 Today Applied Molecular Transport trading halted, news pending 03/03/23 Applied Molecular Transport presents additional data from FILLMORE trial 12/22/22 Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial AMTI Applied Molecular Transport / + 02/08/23 Jefferies Applied Molecular Transport downgraded to Underperform from Hold at Jefferies 01/05/23 BofA BofA double downgrades Applied Molecular with upside catalysts removed 01/05/23 BofA Applied Molecular Transport downgraded to Underperform from Buy at BofA 12/27/22 SVB Securities SVB cuts Applied Molecular Transport to Market Perform, lowers target to $2 AMTI Applied Molecular Transport / + 03/09/23 Applied Molecular Transport reports Q4 EPS (58c), consensus (59c) AMTI Applied Molecular Transport / + 12/27/22 What You Missed On Wall Street On Tuesday 12/27/22 What You Missed On Wall Street This Morning 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning
Earnings	PVH Corp. sees Q1 EPS roughly $1.90, consensus $1.88 » 16:16 03/27/23 03/27 16:16 03/27/23 16:16 PVH PVH Corp. $73.62 / +0.71 (+0.97%) Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/08/23 PVH Corp. names Amber McCann Chief Communications Office 12/01/22 PVH Corp. rises 10.2% 12/01/22 PVH Corp. rises 10.5% 11/30/22 PVH Corp. jumps 9% to $73.38 after Q3 earnings beat, guidance raise PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS 03/20/23 Goldman Sachs PVH Corp. price target raised to $74 from $67 at Goldman Sachs 02/15/23 Wells Fargo PVH Corp. price target raised to $110 from $85 at Wells Fargo 01/23/23 JPMorgan PVH Corp. price target raised to $95 from $77 at JPMorgan PVH PVH Corp. $73.62 / +0.71 (+0.97%) 16:15 Today PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 11/30/22 PVH Corp. sees Q4 adjusted EPS $1.65, consensus $1.70 11/30/22 PVH Corp. reports Q3 adjusted EPS $2.60, consensus $2.15 PVH PVH Corp. $73.62 / +0.71 (+0.97%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 12/01/22 Fly Intel: Pre-market Movers 11/30/22 Fly Intel: After-Hours Movers 03/28/23 PVH Corp. - PVH PVH PVH Corp. $73.62 / +0.71 (+0.97%) 13:04 Today PVH Corp. options imply 5.1% move in share price post-earnings
Technical Analysis	NYSE market internals summary » 16:16 03/27/23 03/27 16:16 03/27/23 16:16 $NYE NYSE Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary

Earnings	PVH Corp. reports Q4 adjusted EPS $2.38, consensus $1.67 » 16:15 03/27/23 03/27 16:15 03/27/23 16:15 PVH PVH Corp. $73.62 / +0.71 (+0.97%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/08/23 PVH Corp. names Amber McCann Chief Communications Office 12/01/22 PVH Corp. rises 10.2% 12/01/22 PVH Corp. rises 10.5% 11/30/22 PVH Corp. jumps 9% to $73.38 after Q3 earnings beat, guidance raise PVH PVH Corp. $73.62 / +0.71 (+0.97%) 03/21/23 UBS PVH Corp. price target lowered to $92 from $100 at UBS 03/20/23 Goldman Sachs PVH Corp. price target raised to $74 from $67 at Goldman Sachs 02/15/23 Wells Fargo PVH Corp. price target raised to $110 from $85 at Wells Fargo 01/23/23 JPMorgan PVH Corp. price target raised to $95 from $77 at JPMorgan PVH PVH Corp. $73.62 / +0.71 (+0.97%) 11/30/22 PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89 11/30/22 PVH Corp. sees Q4 adjusted EPS $1.65, consensus $1.70 11/30/22 PVH Corp. reports Q3 adjusted EPS $2.60, consensus $2.15 11/30/22 Notable companies reporting after market close PVH PVH Corp. $73.62 / +0.71 (+0.97%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 12/01/22 Fly Intel: Pre-market Movers 11/30/22 Fly Intel: After-Hours Movers 03/28/23 PVH Corp. - PVH PVH PVH Corp. $73.62 / +0.71 (+0.97%) 13:04 Today PVH Corp. options imply 5.1% move in share price post-earnings
General news	Treasury Market Summary: » 16:15 03/27/23 03/27 16:15 03/27/23 16:15 $ECON Economic Data / + Treasury Market Summary:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Earnings	Harpoon Therapeutics reports Q4 EPS (55c), consensus (47c) » 16:14 03/27/23 03/27 16:14 03/27/23 16:14 HARP Harpoon Therapeutics / + Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HARP Harpoon Therapeutics / + 03/14/23 Harpoon Therapeutics announces acceptance of five abstracts for AACR meeting 12/11/22 Harpoon presents interim results from Phase 1 evaluating single-agent HPN217 10/04/22 Harpoon Therapeutics appoints Luke Walker as Chief Medical Officer HARP Harpoon Therapeutics / + 12/14/22 Truist Harpoon Therapeutics downgraded to Hold from Buy at Truist 11/15/22 Baird Harpoon Therapeutics downgraded to Neutral from Outperform at Baird 08/29/22 Citi Harpoon Therapeutics price target lowered to $6 from $7 at Citi 08/23/22 Truist Harpoon Therapeutics price target lowered to $7 from $12 at Truist HARP Harpoon Therapeutics / + 11/14/22 Harpoon Therapeutics reports Q3 EPS (35c), consensus (56c) HARP Harpoon Therapeutics / + 12/14/22 Biotech Alert: Searches spiking for these stocks today 12/12/22 Biotech Alert: Searches spiking for these stocks today
Initiation	Repligen initiated with a Buy at Benchmark » 16:12 03/27/23 03/27 16:12 03/27/23 16:12 RGEN Repligen $167.39 / +7.49 (+4.68%) Benchmark analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly RGEN Repligen $167.39 / +7.49 (+4.68%) 02/17/23 Repligen CFO Snodgres sells 5,647 common shares 02/09/23 Repligen appoints Martin Madaus to board of directors 11/01/22 Repligen expands long-term supply agreement with Purolite RGEN Repligen $167.39 / +7.49 (+4.68%) 02/23/23 Craig-Hallum Repligen price target lowered to $220 from $251 at Craig-Hallum 12/13/22 Deutsche Bank Repligen initiated with a Hold at Deutsche Bank 12/06/22 RBC Capital Repligen initiated with a Sector Perform at RBC Capital 11/02/22 Craig-Hallum Repligen price target lowered to $251 from $274 at Craig-Hallum RGEN Repligen $167.39 / +7.49 (+4.68%) 02/22/23 Repligen sees FY23 adjusted EPS $2.61-$2.69, consensus $2.92 02/22/23 Repligen reports Q4 adjusted EPS 68c, consensus 58c 11/01/22 Repligen narrows 2022 adjusted diluted EPS view $3.15-$3.20 from $3.13-$3.20 11/01/22 Repligen reports Q3 adjusted EPS 77c, consensus 68c RGEN Repligen $167.39 / +7.49 (+4.68%) 11/01/22 Fly Intel: Pre-market Movers 10/21/22 Biotech Alert: Searches spiking for these stocks today
Hot Stocks	MaxCyte appoints Douglas Swirsky as CFO » 16:11 03/27/23 03/27 16:11 03/27/23 16:11 MXCT MaxCyte $4.12 / +0.035 (+0.86%) MaxCyte announced Douglas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MXCT MaxCyte $4.12 / +0.035 (+0.86%) 03/08/23 MaxCyte announces formation of new SAB 12/05/22 MaxCyte, Curamys announce SPL for cell and gene therapies 09/28/22 MaxCyte signs strategic platform license with Vertex Pharmaceuticals MXCT MaxCyte $4.12 / +0.035 (+0.86%) 08/14/22 BTIG MaxCyte price target raised to $11 from $10 at BTIG MXCT MaxCyte $4.12 / +0.035 (+0.86%) 03/15/23 MaxCyte sees FY23 revenue growth of between 21%-26% YoY 03/15/23 MaxCyte reports Q4 EPS (5c), consensus (7c) 03/06/23 MaxCyte sees FY23 revenue up 21%-26%, consensus $57.88M 03/06/23 MaxCyte reports preliminary Q4 revenue $12.4M, consensus $12.9M
Hot Stocks	Diamondback Energy joins Oil and Gas Methane Partnership 2.0 » 16:09 03/27/23 03/27 16:09 03/27/23 16:09 FANG Diamondback Energy $128.99 / +3.73 (+2.98%) Diamondback Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options FANG Diamondback Energy $128.99 / +3.73 (+2.98%) 02/21/23 Diamondback Energy sees Q1 oil production 248-252 MBO/d 02/21/23 Diamondback Energy sees FY23 oil production 256 - 262 MBO/d 12/12/22 Diamondback Energy added to Nasdaq-100 Index 11/16/22 Diamondback Energy to acquire Lario Permian for $850M in cash, 4.18M shares FANG Diamondback Energy $128.99 / +3.73 (+2.98%) 08:34 Today Morgan Stanley Diamondback Energy price target lowered to $158 from $168 at Morgan Stanley 06:09 Today Raymond James Diamondback Energy price target lowered to $165 from $205 at Raymond James 03/23/23 Citi Diamondback Energy price target lowered to $157 from $170 at Citi 03/16/23 Barclays Diamondback Energy price target raised to $182 from $166 at Barclays FANG Diamondback Energy $128.99 / +3.73 (+2.98%) 02/21/23 Diamondback Energy reports Q4 adjusted EPS $5.29, consensus $5.22 11/07/22 Diamondback Energy reports Q3 EPS $6.48, consensus $6.33 FANG Diamondback Energy $128.99 / +3.73 (+2.98%) 03/03/23 Notable open interest changes for March 3rd 03/02/23 Diamondback Energy call volume above normal and directionally bullish 02/22/23 Early notable gainers among liquid option names on February 22nd 02/17/23 Unusually active option classes on open February 17th
Initiation	Bowlero initiated with a Buy at Stifel » 16:09 03/27/23 03/27 16:09 03/27/23 16:09 BOWL Bowlero $15.23 / +0.395 (+2.66%) Stifel analyst Steven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events BOWL Bowlero $15.23 / +0.395 (+2.66%) 03/16/23 Bowlero continues expansion in Florida with two acquisitions, terms undisclosed 03/14/23 Bowlero to acquire Paradise Lanes Entertainment Center in Washington State 02/21/23 Bowlero CEO sells $5.30M in common stock 01/24/23 Bowlero CEO sells $2.76M in common stock BOWL Bowlero $15.23 / +0.395 (+2.66%) 03/17/23 JPMorgan Bowlero price target raised to $20 from $18 at JPMorgan 03/08/23 Canaccord Bowlero initiated with a Buy at Canaccord 02/24/23 Craig-Hallum Craig-Hallum initiates 'exciting growth story' Bowlero with a Buy 02/24/23 Craig-Hallum Bowlero initiated with a Buy at Craig-Hallum BOWL Bowlero $15.23 / +0.395 (+2.66%) 02/15/23 Bowlero reports Q2 adjusted EBITDA $97M, up 45.2% y/y 11/16/22 Bowlero reports Q1 adjusted EBITDA $65.3M, up 11% y/y 17 Mar BOWL Bowlero $15.23 / +0.395 (+2.66%) 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/15/23 Fly Intel: After-Hours Movers 01/17/23 Fly Insider: Coinbase, Buckle among week's notable insider trades 11/16/22 Fly Intel: After-Hours Movers 03/28/23 Bowlero
Earnings	FGI Industries sees FY23 revenue $145M-$163M, two estimates $154.78M » 16:07 03/27/23 03/27 16:07 03/27/23 16:07 FGI FGI Industries $1.94 / +0.06 (+3.19%) Sees FY23 adjusted net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings Events FGI FGI Industries $1.94 / +0.06 (+3.19%) 16:06 Today FGI Industries reports Q4 EPS 7c vs. 15c last year 03/28/23 FGI Industries - FGI
Hot Stocks	WM Argyle Fund issues statement regarding Broadwind director appointment » 16:07 03/27/23 03/27 16:07 03/27/23 16:07 BWEN Broadwind $3.40 / -0.05 (-1.45%) WM Argyle Fund, which has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BWEN Broadwind $3.40 / -0.05 (-1.45%) 07:20 Today Broadwind names Jeanette Press to board of directors 02/24/23 WM Argyle Fund calls Broadwind loan default 'indefensible for management' 01/19/23 Broadwind confirms receipt of notice from WM Argyle Fund 01/18/23 WM Argyle Fund nominates full slate of candidates to Broadwind board BWEN Broadwind $3.40 / -0.05 (-1.45%) 01/17/23 H.C. Wainwright Broadwind upgraded to Buy from Neutral at H.C. Wainwright 01/12/23 Craig-Hallum Broadwind price target raised to $9 from $4 at Craig-Hallum BWEN Broadwind $3.40 / -0.05 (-1.45%) 03/09/23 Broadwind sees FY23 revenue $200M-$220M, consensus $206.53M 03/09/23 Broadwind reports Q4 EPS (14c), consensus (15c) 11/08/22 Broadwind reports Q3 EPS (9c), consensus (6c) BWEN Broadwind $3.40 / -0.05 (-1.45%) 02/02/23 Largest borrow rate increases among liquid names 01/27/23 Largest borrow rate increases among liquid names
Earnings	FGI Industries reports Q4 EPS 7c vs. 15c last year » 16:06 03/27/23 03/27 16:06 03/27/23 16:06 FGI FGI Industries $1.94 / +0.06 (+3.19%) Reports Q4 revenue $31.8M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Events 03/28/23 FGI Industries - FGI

Initiation	Carrier Global initiated with an Outperform at Oppenheimer » 16:06 03/27/23 03/27 16:06 03/27/23 16:06 CARR Carrier Global $44.26 / +0.345 (+0.79%) Oppenheimer initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CARR Carrier Global $44.26 / +0.345 (+0.79%) 02/06/23 Carrier Global strengthens climate goals 12/07/22 Carrier Global raises quarterly dividend 23% to 18.5c per share 10/27/22 Carrier Global approves $2B share repurchase authorization CARR Carrier Global $44.26 / +0.345 (+0.79%) 03/22/23 Barclays Carrier Global price target lowered to $50 from $51 at Barclays 02/14/23 Argus Carrier Global price target raised to $52 from $50 at Argus 02/09/23 Citi Carrier Global price target raised to $48 from $45 at Citi 02/08/23 Barclays Carrier Global price target raised to $51 from $47 at Barclays CARR Carrier Global $44.26 / +0.345 (+0.79%) 02/07/23 Carrier Global sees FY23 adjusted EPS $2.50-$2.60, consensus $2.56 02/07/23 Carrier Global reports Q4 adjusted EPS 40c, consensus 40c 10/27/22 Carrier Global narrows FY22 adjusted EPS view to $2.30-$2.35 from $2.25-$2.35 10/27/22 Carrier Global reports Q3 adjusted EPS 70c, consensus 65c 04/20/23 Carrier Global Corporation
Initiation	Lennox initiated with a Perform at Oppenheimer » 16:06 03/27/23 03/27 16:06 03/27/23 16:06 LII Lennox $243.99 / -0.1 (-0.04%) Oppenheimer analyst Noah… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LII Lennox $243.99 / -0.1 (-0.04%) 12/20/22 Xylem names Matthew Pine as COO, effective January 1, 2023 12/14/22 Lennox sees growth in revenue, margin and EPS in 2023 12/14/22 Lennox sees FY23 CapEx $250M LII Lennox $243.99 / -0.1 (-0.04%) 02/01/23 Wells Fargo Lennox price target raised to $300 from $288 at Wells Fargo 02/01/23 Barclays Lennox price target raised to $248 from $240 at Barclays 12/16/22 Mizuho Lennox upgraded to Neutral from Underperform at Mizuho 12/15/22 Deutsche Bank Lennox price target raised to $300 from $284 at Deutsche Bank LII Lennox $243.99 / -0.1 (-0.04%) 01/31/23 Lennox still sees 2023 adjusted EPS $14.25-$15.25, consensus $14.82 01/31/23 Lennox reports Q4 adjusted EPS $2.63, consensus $2.55 12/14/22 Lennox introduces long-term financial targets for 2026 12/14/22 Lennox sees FY23 adjusted EPS $14.25-$15.25, consensus $14.79 LII Lennox $243.99 / -0.1 (-0.04%) 12/14/22 What You Missed On Wall Street On Wednesday 12/14/22 What You Missed On Wall Street This Morning 12/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/18/23 Lennox International Inc
Conference/Events	JPMorgan autos/auto parts analyst holds an analyst/industry conference call » 16:04 03/27/23 03/27 16:04 03/27/23 16:04 Autos & Auto Parts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Initiation	Trane initiated with a Perform at Oppenheimer » 16:04 03/27/23 03/27 16:04 03/27/23 16:04 TT Trane $180.92 / -1.1 (-0.60%) Oppenheimer analyst Noah… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TT Trane $180.92 / -1.1 (-0.60%) 02/09/23 Trane raises quarterly dividend 12% to 75c from 67c per share 01/24/23 Trane rises 8.2% 01/24/23 Trane Technologies trading resumes 01/24/23 Trane Technologies trading halted, volatility trading pause TT Trane $180.92 / -1.1 (-0.60%) 03/07/23 UBS Trane price target raised to $224 from $200 at UBS 02/08/23 Argus Trane price target raised to $200 from $185 at Argus 02/03/23 Deutsche Bank Trane price target raised to $184 from $170 at Deutsche Bank 02/03/23 RBC Capital Trane price target raised to $177 from $164 at RBC Capital TT Trane $180.92 / -1.1 (-0.60%) 02/02/23 Trane sees 2023 adjusted EPS $8.20-$8.50, consensus $7.89 02/02/23 Trane reports Q4 adjusted EPS $1.82, consensus $1.65 11/02/22 Trane raises FY22 adjusted EPS view to $7.15-$7.20 from $7.05-$7.15 11/02/22 Trane reports Q3 adjusted EPS $2.27, consensus $2.12
Hot Stocks	Applied Molecular Transport CEO Tahir Mahmood to leave in workforce reduction » 16:04 03/27/23 03/27 16:04 03/27/23 16:04 AMTI Applied Molecular Transport / + Applied Molecular… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AMTI Applied Molecular Transport / + 16:00 Today Applied Molecular Transport trading halted, news pending 03/03/23 Applied Molecular Transport presents additional data from FILLMORE trial 12/22/22 Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial 11/10/22 Applied Molecular Transport announces FDA ODD granted to AMT-101 AMTI Applied Molecular Transport / + 02/08/23 Jefferies Applied Molecular Transport downgraded to Underperform from Hold at Jefferies 01/05/23 BofA BofA double downgrades Applied Molecular with upside catalysts removed 01/05/23 BofA Applied Molecular Transport downgraded to Underperform from Buy at BofA 12/27/22 SVB Securities SVB cuts Applied Molecular Transport to Market Perform, lowers target to $2 AMTI Applied Molecular Transport / + 03/09/23 Applied Molecular Transport reports Q4 EPS (58c), consensus (59c) AMTI Applied Molecular Transport / + 12/27/22 What You Missed On Wall Street On Tuesday 12/27/22 What You Missed On Wall Street This Morning 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning